Results 151 to 160 of about 14,468 (240)

Current perspectives on psychedelic treatments in Europe. [PDF]

Lancet Reg Health Eur
Madero S, Soto-Angona O, Ona G, Sanchez-Moreno J, Vieta E.   +4 more
europepmc   +1 more source

Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials. [PDF]

J Clin Med
Dominiak M, Gędek A, Modrzejewski S, Permoda-Pachuta A, Antosik AZ.   +4 more
europepmc   +1 more source

Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences. [PDF]

Int J Drug Policy
Olofsson M, Osika W, Goldberg SB, Hendricks PS, Petrovic P, White T, Stenfors CUD, Chaturvedi S, Simonsson O.   +8 more
europepmc   +1 more source

The Role of Psychedelics in Contemporary Psychological and Interdisciplinary Inquiry. [PDF]

J Pers Med
Soylemez KK, de Boo EM, Susuzlu A, Lusher J.   +3 more
europepmc   +1 more source

Toward a Free Housing Market. By Daniel Jay Baum. Coral Gables: University of Miami Press. 1971. Pp. xiii, 237. $10.00. [PDF]

, 1971

core   +1 more source

DMT-Induced Shifts in Criticality Correlate with Self-Dissolution. [PDF]

J Neurosci
Irrmischer M, Aqil M, Luan L, Wang T, Engelbregt H, Carhart-Harris R, Linkenkaer-Hansen K, Timmermann C.   +7 more
europepmc   +1 more source

Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection? [PDF]

, 2016
Frecska, Ede, Szabó, Attila
core   +3 more sources

Excusing Psychedelics and Accommodating Psychedelics

The American Journal of Bioethics
openaire   +2 more sources

Association between lifetime co-use of classic psychedelics and cannabis and prostate cancer diagnosis among US adults 50 years and older. [PDF]

Sci Rep
Baral A, Pan Y, Hlaing WM, Garcia-Romeu A, Pinheiro PS, Vidot DC.   +5 more
europepmc   +1 more source

Psychedelic studies in nonhuman primates: Past and future. [PDF]

Mol Psychiatry
Masthay JC, Kwan AC, Chang SWC.
europepmc   +1 more source